Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05000281
Other study ID # W81XWH2020063
Secondary ID
Status Recruiting
Phase Phase 3
First received
Last updated
Start date September 14, 2021
Est. completion date December 2024

Study information

Verified date October 2021
Source Major Extremity Trauma Research Consortium
Contact Tara Taylor Joseph, MPH
Phone 410-614-6081
Email ttaylo56@jhu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed study is a two arm, pragmatic, randomized controlled multicenter Phase III noninferiority trial. 1,000 patients with tibia fractures treated with intramedullary (IM) nail will be randomized into two treatment arms. The control arm will receive standard pain management and no NSAIDs. The treatment arm will receive standard pain management plus up to six weeks of NSAIDs (3 weeks of prescribed medication followed by 3 weeks of medication PRN).


Description:

The proposed study is a two arm, pragmatic, randomized controlled multicenter Phase III noninferiority trial. Patients with diaphyseal tibia fractures treated with intramedullary (IM) nail will be randomized into two treatment arms. The control arm will receive standard pain management with no NSAIDs. The treatment arm will receive standard pain management plus up to six weeks of NSAIDs (3 weeks of prescribed medication followed by 3 weeks of medication PRN). The hypothesis is that pain management using up to 6 weeks of NSAIDs will result in improved pain control and lower opioid consumption but demonstrate non-inferior levels of complications compared to standard of care pain management. The aim of the study is to: Specific Aim: Evaluate the effect of standard pain management without NSAIDs (Group 1) vs. standard pain management plus up to 6 weeks of NSAIDs (Group 2) in the treatment of tibial shaft fractures. Primary Hypothesis: When compared to patients who received standard of care pain management, patients treated with up to 6 weeks of NSAIDs will have noninferior rates of surgery for to promote union at one year. Secondary Hypotheses: When compared to patients who received standard of care pain management without NSAIDs, patients treated with up to 6 weeks of NSAIDs will benefit from (1) reduced opioid utilization; (2) reduced levels of persistent pain; (3) reduced pain interference; (4) improved functional outcomes; (5) noninferior rates of analgesic treatment related side effects; and (6) noninferior rates of radiographic union. Study design: At time of IM nailing surgery for acute diaphyseal tibia fracture, patients will be randomized to treatment or control group. Treatment patients will receive a standard of care pain regimen and oral ibuprofen 600 mg three times a day (tid) for up to six weeks (3 weeks of prescribed medication followed by 3 weeks of medication PRN). Control patients will receive a standard of care pain regimen prescribed by the treating physician and may not use NSAIDs. Patients in both arms will be permitted to receive 81mg of daily aspirin. Patient medication adherence will be documented via an electronic data collection interface through mobile or web-based application. Patients who do not have access to documenting adherence electronically will be given paper-based medication dairies by the research team. Follow-Up: Clinical, functional, and radiographic follow-up will be conducted at typical standard of care intervals of 2-3 weeks, 6 weeks, 3 months, 6 months, and one year. Study duration: 3.75 years (18 month accrual, 24 month final follow-up, 3 month analysis and writing). Sample size: 1,000 (500 per arm (2) arms) Number of study sites: 14 sites (13 Civilian and 1 Military Treatment Facility) Study population: The study population will consist of a relatively homogeneous group of 1,000 patients with orthopaedic trauma: patients with open or closed diaphyseal tibia fractures. Since military combat injuries are typically open, open fractures will be included in this study. However, since post-surgical pain after these injuries is not limited to the open fractures, and the practices of pain management should apply to both open and closed injuries, closed versions of these high energy injuries in the study population will also be included.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date December 2024
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - All patients with open (Grade I, II, of IIIa) or closed tibia fractures treated with a nail. - Patients 18-80 years old inclusive. - Patients able to be followed at a Major Extremity Trauma & Rehabilitation (METRC) facility for at least 12 months following injury Exclusion Criteria: - Patient unable to provide informed consent - Patients who are current - intravenous drug user. - Patients with a history of allergy to the study drugs. - Patients unable to swallow oral medications or without functioning GI tract. - Patients with a history of gastrointestinal bleeds or gastric perforation. - Patients with a history of stroke or heart attack. - Patients requiring an aspirin or NSAID regimen except for low dose aspirin, 81mg. - Patients with any bleeding disorders. - Patients with severe renal failure [glomerular filtration rate (GFR):<30]. Patients with moderate renal failure [GFR: 30-59] may participate in the study at a modified dose. - Patients undergoing daily treatment with systemic glucocorticoids before surgery. - Patients likely to have severe problems maintaining follow-up, including patients diagnosed with a severe psychiatric conditions, patients who live too far outside the hospital's catchment area, patients who are incarcerated and patients who have unstable housing situations. - Patients with a Glasgow Coma Scale (GCS) <15 at discharge. - Patients with a closed head injury that precludes NSAIDS. - Patients who are pregnant or lactating at time of screening - Patients with a bone graft procedure planned for a future date at the time of initial definitive fixation surgery.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ibuprofen
600 mg Ibuprofen 3 times a day for up to six weeks.

Locations

Country Name City State
United States University of Utah Salt Lake City Utah

Sponsors (1)

Lead Sponsor Collaborator
Major Extremity Trauma Research Consortium

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Numbers of participants with nonunion (secondary surgery to promote union) Nonunion will be assessed by the presence of a secondary surgery to promote union after 3 months post definitive fixation surgery. Surgery operative notes and radiographs of each case will be independently reviewed by members of the METRC Central Adjudication Committee and if at least 2 members agree with the assessment of secondary surgery to promote union, no further review will be necessary. The METRC Central Adjudication Committee will convene to discuss the cases for which there is disagreement regarding nonunion assessment. Between 3 months and 12 months after definitive fixation surgery
Secondary Pain as assessed by the Brief Pain Inventory (BPI) The Brief Pain Inventory (BPI) is a widely used, 15-item measure of pain intensity and interference with daily life and will be assessed at baseline, 3, 6, and 12 months post definitive fixation surgery. It has been extensively validated in both English and Spanish, and also includes questions about pain treatments and the effectiveness of these treatments.46 The BPI pain intensity domain is compatible with the IMMPACT guidelines for assessing pain in clinical trials and the FDA Guidance for Industry on the use of Patient-Reported Outcome Measures. Baseline, 3, 6, 12, months
Secondary Pain interference as assessed by Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference One of the domains assessed by The Patient Report Outcomes Measurement Information System (PROMIS) Computer Adaptive Test (CAT) includes Pain Interference. CATs present an advantage over traditional measures in that they target only the most relevant items to each patient and can thus be used to obtain precise measurements with 4-6 items, making assessment across multiple domains feasible. CATs can also extend the ceiling and floor of individual domains, potentially enhancing responsiveness. Baseline, 3, 6, 12, months
Secondary Physical and Psychosocial functioning as assessed by Patient Report Outcomes Measurement Information System (PROMIS) Self -Reported Measures of Physical and Psychosocial Function will be assessed using the Patient Report Outcomes Measurement Information System (PROMIS) Computer Adaptive Test (CAT) item banks, a product of the NIH Roadmap for Medical Research. CATs present an advantage over traditional measures in that they target only the most relevant items to each patient and can thus be used to obtain precise measurements with 4-6 items, making assessment across multiple domains feasible. In this study the following PROMIS domains will be used: Physical function, Depression, Anxiety, Pain Inference, Fatigue, Sleep Disturbance, Ability to Participate in Social Roles and Activities and Psychosocial Illness Impact. Baseline, 3, 6, 12, months
Secondary Radiographic union as assessed by the modified Radiographic Union Scale in Tibial Fractures (mRUST) Radiographic union will be based on the modified RUST(mRUST) score assessed between 3 months and 12 months after definitive fixation surgery. The four cortices of the tibia fracture will be assessed and given a score from 1-4, 1=not healed, 4=healed. The mRUST score is the sum of the 4 cortical scores (4-16) and a score of 13 or greater is considered a healed fracture.
Radiographic examinations at 3, 6 and 12 months by an adjudication committee comprised of METRC investigators will be evaluated based on AP and lateral x-rays.
Between 3 months and 12 months after definitive fixation surgery
See also
  Status Clinical Trial Phase
Completed NCT05613257 - Distal Targeter vs Free-hand N/A
Withdrawn NCT00240396 - Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture N/A
Withdrawn NCT04768478 - CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF Phase 4
Completed NCT03649360 - Knee Pain After Intramedullary Nailing in the Tibia
Recruiting NCT05668182 - A Case Series: TRUMATCH Graft Cage for Segmental Long Bone Defects
Recruiting NCT05859451 - Effect of Tobacco Heating System (THS) on Closed Tibia Fracture Healing N/A
Not yet recruiting NCT06280417 - Unreamed Intramedullary Tibial Nailing in Treatment of Open IIIa Diaphyseal Tibial Fractures in Adults
Completed NCT03936972 - Ilizarov Frame or Uni Planar External Fixator in the Cost-conscious Era
Completed NCT06436365 - Is the Expert Nail With Poller Screws Superior to the Distal Tibial Locked Plate in the Management of Short Oblique Distal Tibial Fractures? N/A
Completed NCT03314623 - Immediate Mobilization After Plate Osteosynthesis of Proximal Tibial Fractures - A Cohort Study
Recruiting NCT05151926 - Limb Injuries and Post Injury Rehabilitation Trials - Tibial Shaft Fracture N/A
Recruiting NCT01047826 - M.I.P.O. vs Intramedullary Nailing in Tibia Fractures N/A
Active, not recruiting NCT04960722 - OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting N/A
Completed NCT01691599 - Infection Rates Following Internal Fixation of Open and Closed Tibia Fractures in India
Completed NCT00793637 - Evaluation of Handling and Possible Complications Related to the Newly Developed Angular Stable Locking System (ASLS)
Completed NCT00888550 - Splinting Versus Not Splinting of the Distal Lower Extremity After Intramedullary Nailing for Tibial Fractures N/A
Recruiting NCT04674592 - Biomarkers in the Diagnosis of Acute Compartment Syndrome